Jonathan May
Senior Scientist at Acuitas Therapeutics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Acuitas Therapeutics
-
Canada
-
Biotechnology
-
1 - 100 Employee
-
Senior Scientist
-
May 2023 - Present
Vancouver, British Columbia, Canada
-
-
-
University of Southampton
-
United Kingdom
-
Higher Education
-
700 & Above Employee
-
Research Fellow
-
2018 - 2023
Southampton, United Kingdom
-
-
-
Newcastle University
-
United Kingdom
-
Higher Education
-
700 & Above Employee
-
Research Associate
-
2017 - 2018
Newcastle upon Tyne, United Kingdom Developing a stimuli-sensitive drug delivery technology for brain cancer.
-
-
-
UBC Faculty of Pharmaceutical Sciences
-
Canada
-
Higher Education
-
1 - 100 Employee
-
Research Associate
-
2014 - 2016
Vancouver, Canada Research, Teaching and Lab management
-
-
-
Ontario Institute for Cancer Research
-
Canada
-
Research Services
-
200 - 300 Employee
-
Nanomedicine Pdf, Med Chem Group
-
2011 - 2014
Toronto, Canada Development and optimization of novel nanoparticle formulations for drug delivery.
-
-
-
-
Medicinal Chemist / Liposomal Formulation Scientist (Industrial Post-Doc)
-
2008 - 2010
Managed multiple projects and developed collaborations to meet company objectives with responsibilities in two key areas: 1) Member of a successful Medicinal Chemistry team, responsible for synthesis of a wide variety of molecular targets (small molecules, heterocycles and bio-conjugates). 2) Responsible for the successful formulation and characterization of novel targetted liposomes for gene therapy and vaccine based approaches. Responsible for setting up the first fully… Show more Managed multiple projects and developed collaborations to meet company objectives with responsibilities in two key areas: 1) Member of a successful Medicinal Chemistry team, responsible for synthesis of a wide variety of molecular targets (small molecules, heterocycles and bio-conjugates). 2) Responsible for the successful formulation and characterization of novel targetted liposomes for gene therapy and vaccine based approaches. Responsible for setting up the first fully functioning Medicinal Chemistry lab at the CDRD. Show less
-
-
-
The University of British Columbia
-
Canada
-
Higher Education
-
700 & Above Employee
-
Post-Doc / Research Associate II
-
2003 - 2007
Vancouver, Canada Awarded a Post-Doctoral Fellowship from The Royal Society, UK 1) Prepared hydroxypyroloindole derivatives and used these to prepare bicyclic peptides (amatoxins). 2) Studied a new found AP-lyase activity of a previously selected DNAzyme.
-
-
-
Eurogentec
-
Belgium
-
Biotechnology Research
-
200 - 300 Employee
-
Synthetic Chemist CASE studentship Intern
-
1999 - 2003
Synthetic chemist whose research led to a product that was developed for the biotechnology market
-
-